The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?
After menopause, estradiol is primarily synthesized in peripheral tissues by the enzyme aromatase, encoded by CYP19A1. CYP19A1 variation associates with circulating estradiol in postmenopausal women and this variation is best represented by the intronic variant rs727479. This variation appears to ha...
Saved in:
Main Authors: | Dylan M. Glubb (Author), Tracy A. O'Mara (Author), Jannah Shamsani (Author), Amanda B. Spurdle (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Placental ESRRG-CYP19A1 Expressions and Circulating 17-Beta Estradiol in IUGR Pregnancies
by: Gaia Maria Anelli, et al.
Published: (2019) -
Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive age
by: E V Ivanova, et al.
Published: (2016) -
A non-synonymous coding change in the <it>CYP19A1 </it>gene Arg264Cys (rs700519) does not affect circulating estradiol, bone structure or fracture
by: Wang Jenny Z, et al.
Published: (2011) -
CYP1A1, CYP1B1, GSTM1 and GSTT1 genetic variants and breast cancer risk in Mexican women
by: Angélica García-Martínez, et al.
Published: (2017) -
A Novel Homozygous CYP19A1 Gene Mutation: Aromatase Deficiency Mimicking Congenital Adrenal Hyperplasia in an Infant without Obvious Maternal Virilisation
by: Fatma Dursun, et al.
Published: (2019)